CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis

Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu

Clin Mol Hepatol. 2021;27(1):186-196. Published online 2020 December 3 DOI: https://doi.org/10.3350/cmh.2020.0180

Direct-Acting Antivirals (DAAs): Drug-Drug Interactions (DDIs) in the Treatment of Hepatitis C Virus (HCV)

Sabina Steiner, Nikola Raguž-Lučić, Damir Erceg

Update on Hepatitis C. 2017;

Link1

Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infection

Nadège Néant, Caroline Solas

International Journal of Antimicrobial Agents. 2020;56(1):105571

Link1 Link2

Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?

Poonam Mishra, Minjun Chen

Gastroenterology. 2017;152(6):1270-1274

Link1 Link2

1201 IN VITRO ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN DIRECT-ACTING ANTIVIRALS AND CYCLOPHILIN INHIBITORS IN THE TREATMENT OF CHRONIC HEPATITIS C

S.H. Park, W. Ward, B. Beaudet, S. Schock, R. Randolph, S. Wring

Journal of Hepatology. 2012;56:S476

Link1 Link2

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report

Mario Enrico Canonico, Giuseppe Damiano Sanna, Roberta Siciliano, Fernando Scudiero, Giovanni Esposito, Guido Parodi

Frontiers in Pharmacology. 2022;13:

Link1

Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain

Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo

Gastroenterología y Hepatología (English Edition). 2019;42(8):465-475

Link1 Link2

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis

Clinical and Molecular Hepatology. 2021;27(1):186-196

Link1

Link2 Link3

Drug-drug interactions with direct-acting antivirals — less is more

Grace Lai-Hung Wong

Clinical and Molecular Hepatology. 2021;27(1):81-82

Link1

Link2 Link3

Drug Interactions of Hepatitis C Direct-Acting Antivirals in the HIV-Infected Person

O. El-Sherif, D. Back

Current HIV/AIDS Reports. 2015;12(3):336-343

Link1

Link2 Link3

Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management

Michael Curry, Naoky Tsai, Bruce Bacon, Steven Flamm, Zobair Younossi, Scott Milligan, Nicole Wick, Nezam Afdhal

Journal of Hepatology. 2020;73:S355-S356

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.